000 | 01334 a2200385 4500 | ||
---|---|---|---|
005 | 20250516053450.0 | ||
264 | 0 | _c20130129 | |
008 | 201301s 0 0 eng d | ||
022 | _a1755-5922 | ||
024 | 7 |
_a10.1111/j.1755-5922.2011.00267.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFung, En C | |
245 | 0 | 0 |
_aStatin myopathy: a lipid clinic experience on the tolerability of statin rechallenge. _h[electronic resource] |
260 |
_bCardiovascular therapeutics _cOct 2012 |
||
300 |
_ae212-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnticholesteremic Agents _xadverse effects |
650 | 0 | 4 |
_aCreatine Kinase _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscular Diseases _xchemically induced |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 |
_aSimvastatin _xadverse effects |
700 | 1 | _aCrook, Martin A | |
773 | 0 |
_tCardiovascular therapeutics _gvol. 30 _gno. 5 _gp. e212-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1755-5922.2011.00267.x _zAvailable from publisher's website |
999 |
_c21125955 _d21125955 |